We are live on ! Find out more
NRS

Neville Rodie & Shaw Portfolio holdings

AUM $1.55B
1-Year Est. Return 46.95%
This Fund
S&P 500
This Quarter Est. Return
+3.75%
1 Year Est. Return
+46.95%
3 Year Est. Return
+114.59%
5 Year Est. Return
+149.24%
10 Year Est. Return
+498%
AUM
$948M
AUM Growth
+$41M
Cap. Flow
+$12.7M
Cap. Flow %
1.34%
Top 10 Hldgs %
27.51%
Holding
266
New
20
Increased
64
Reduced
83
Closed
5

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$8.88M
2
WAB icon
Wabtec
WAB
+$4.45M
3
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
+$2.26M
4
JPM icon
JPMorgan Chase
JPM
+$1.62M
5
XLRN
Acceleron Pharma
XLRN
+$1.57M

Top Sells

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$6.45M
2
WFC icon
Wells Fargo
WFC
+$1.74M
3
HSIC icon
Henry Schein
HSIC
+$1.42M
4
UPS icon
United Parcel Service
UPS
+$1.09M
5
CB icon
Chubb
CB
+$910K

Sector Composition

Rank Sector Weight
1 Healthcare 16.99%
2 Industrials 14.77%
3 Financials 14.58%
4 Technology 13.43%
5 Energy 11.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MNDT
126
DELISTED
Mandiant, Inc. Common Stock
MNDT
$953K 0.1%
61,950
– –
NUE icon
127
Nucor
NUE
$62.1B
$940K 0.1%
15,044
-250
-2% -$16K
DE icon
128
Deere & Co
DE
$168B
$898K 0.09%
6,422
-3,350
-34% -$494K
WMB icon
129
Williams Companies
WMB
$86.1B
$876K 0.09%
32,300
– –
SHPG
130
DELISTED
Shire pic
SHPG
$843K 0.09%
4,996
– –
ROK icon
131
Rockwell Automation
ROK
$49B
$815K 0.09%
4,900
– –
WMT icon
132
Walmart Inc
WMT
$890B
$799K 0.08%
28,002
-1,404
-5% -$39.9K
NXPI icon
133
NXP Semiconductors
NXPI
$60.4B
$798K 0.08%
7,300
– –
WBA
134
DELISTED
Walgreens Boots Alliance
WBA
$792K 0.08%
13,191
-148
-1% -$9.53K
TT icon
135
Trane Technologies
TT
$106B
$754K 0.08%
8,400
– –
NVS icon
136
Novartis
NVS
$297B
$750K 0.08%
11,084
– –
MKC icon
137
McCormick & Company Non-Voting
MKC
$14.2B
$731K 0.08%
12,600
– –
C icon
138
Citigroup
C
$226B
$724K 0.08%
10,824
+1,007
+10% +$69.3K
ITW icon
139
Illinois Tool Works
ITW
$85.3B
$723K 0.08%
5,222
– –
KNX icon
140
Knight Transportation
KNX
$11.4B
$715K 0.08%
18,700
-568
-3% -$23.4K
ZBH icon
141
Zimmer Biomet
ZBH
$18.4B
$711K 0.08%
6,570
– –
TROW icon
142
T. Rowe Price
TROW
$24.3B
$705K 0.07%
6,075
– –
MRSH
143
Marsh
MRSH
$91.5B
$699K 0.07%
8,530
+2,530
+42% +$207K
GWW icon
144
W.W. Grainger
GWW
$60.2B
$687K 0.07%
2,229
– –
ENB icon
145
Enbridge
ENB
$112B
$674K 0.07%
18,875
+57
+0.3% +$1.8K
RDS.A
146
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$650K 0.07%
9,381
-7,825
-45% -$542K
HPQ icon
147
HP
HPQ
$27.5B
$645K 0.07%
28,421
– –
COL
148
DELISTED
Rockwell Collins
COL
$620K 0.07%
4,600
– –
EQR icon
149
Equity Residential
EQR
$25.1B
$573K 0.06%
9,000
– –
OKE icon
150
Oneok
OKE
$54.5B
$559K 0.06%
8,000
– –
4 5
6
7 8

Similar funds

BGCP
Bristol Gate Capital Partners Toronto, Ontario, Canada $1.55B AUM 12.75% 1-Year Est. Return
MSA
MUFG Securities Americas New York $1.55B AUM 28.4% 1-Year Est. Return
CET
Clean Energy Transition London, United Kingdom $1.54B AUM 34.41% 1-Year Est. Return
ICM
Irenic Capital Management New York $1.54B AUM 12.79% 1-Year Est. Return
CCM
Cinctive Capital Management New York $1.53B AUM 48.83% 1-Year Est. Return
TNBTD
Trustmark National Bank Trust Department Jackson, Mississippi $1.56B AUM 16.53% 1-Year Est. Return
MCP
Meridiem Capital Partners Dallas, Texas $1.53B AUM 17.03% 1-Year Est. Return
SG
Sienna Gestion Paris, France $1.53B AUM 27.73% 1-Year Est. Return

Neville Rodie & Shaw's Q2 2018 Portfolio in Review

As of Q2 2018, Neville Rodie & Shaw held 266 positions worth $948M, up 4.5% from $907M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Neville Rodie & Shaw's Q2 2018 filing shows 20 new, 64 increased, 83 reduced and 5 closed positions. Its largest new stake was Acceleron Pharma: 42,964 shares worth $2.08M. The largest sale was Invesco QQQ Trust, an estimated $6.45M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 17% a quarter earlier, followed by Industrials and Financials.

  • Neville Rodie & Shaw's largest Q2 2018 buy was Acceleron Pharma: 42,964 shares worth $2.08M.
  • Neville Rodie & Shaw added most to Allergan plc in Q2 2018, an estimated $8.88M increase.
  • Neville Rodie & Shaw's biggest Q2 2018 reduction was Wells Fargo, cutting an estimated $1.74M.
  • Neville Rodie & Shaw fully exited Invesco QQQ Trust in Q2 2018, selling an estimated $6.45M.
  • Neville Rodie & Shaw's ten largest holdings make up 28% of its $948M portfolio in Q2 2018.
  • Neville Rodie & Shaw opened 20 new positions and closed 5 in Q2 2018.
  • Neville Rodie & Shaw's portfolio value rose 4.5% quarter-over-quarter to $948M.

Based on Neville Rodie & Shaw's 13F filing for Q2 2018, filed 3 Jul 2018.